𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The ongoing saga of osteoporosis treatment

✍ Scribed by BS Komm; PVN Bodine

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
13 KB
Volume
73
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis

On page 280 of the article cited above the following sentence was printed incorrectly:

For example, alendronate increases BMD in up to 7% of postmenopausal women, which is somewhat higher than what is reported for Premarin or 17␀-estradiol [Liberman et al., 1995].

The correct sentence is printed below: For example, alendronate increases BMD up to 7% in postmenopausal women, which is somewhat higher than what is reported for Premarin or 17␀-estradiol [Liberman et al., 1995].

πŸ“œ SIMILAR VOLUMES

The ongoing saga of osteoporosis treatme
The ongoing saga of osteoporosis treatment
✍ Barry S. Komm; Peter V.N. Bodine πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 46 KB πŸ‘ 1 views
ChemInform Abstract: Emerging Therapies
ChemInform Abstract: Emerging Therapies for the Prevention or Treatment of Postmenopausal Osteoporosis
✍ Masahiko Sato; Timothy A. Grese; Jeffrey A. Dodge; Henry U. Bryant; Charles H. T πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons βš– 24 KB πŸ‘ 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a β€œFull Text” option. The original article is trackable v

Synthesis of Novel Bone-Targeted Agents
Synthesis of Novel Bone-Targeted Agents (I) for Treatment of Osteoporosis.
✍ Junbo Wang; Chunhao Yang; Huasheng Ding; Yueming Yan; Xihan Wu; Yuyuan Xie πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons βš– 11 KB

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.